Director, Group Lead, Data Surveillance, Clinical Data Sciences

As part of the Clinical Data Sciences group, an integral delivery unit within the Clinical Development & Operations (CD&O) organization, the Director, Group Lead, Data Surveillance, is responsible for delivery of all technical and operational aspects of RBM, including timely and high-quality risk-based monitoring analytics supporting the Pfizer portfolio. The Director, Group Lead, Data Surveillance will manage the Central Monitoring groups, providing oversight of central monitoring deliverables and managerial oversight of Central Monitors. The Central Monitors will support an approach to clinical trial monitoring which utilizes data and site level information to determine needs for performing on-site, remote and centralized activities and focuses resources on risks that have the most potential to impact patients’ safety and data quality. Overall, responsible for defining, delivering and executing the enterprise level RBM implementation plan including strategy and process definition, technology implementation, training, enterprise change management, and communication plan